An operational security failure allowed researchers to recover data that the INC ransomware gang stole from a dozen U.S.

Change signals a shift away from legacy monitoring packs toward modern observability and Azure-based monitoring tools.

Microsoft has announced that SCOM Management Packs for SSRS, PBIRS, and SSAS will reach End of Support in January 2027, forcing enterprise migration to Azure Monitor.

Microsoft will retire SCOM SQL monitoring packs in 2027, pushing customers toward Azure Monitor and cloud billing.

General availability on newer Linux distributions and CU1 signal a push toward stability, security and production readiness.

Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...

Recursion Pharmaceuticals (RXRX) just delivered encouraging Phase 1b/2 TUPELO data for its FAP drug candidate REC-4881, and that clinical update has quickly reshaped how both Wall Street and ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...